Chargement en cours...

Vinorelbine and Gemcitabine as Second- or Third-Line Therapy for Malignant Pleural Mesothelioma

OBJECTIVES: Pemetrexed-cisplatin is the only FDA-approved regimen for malignant pleural mesothelioma (MPM), and the impact on survival is modest. No drugs have been shown to improve survival as second-line therapy, yet vinorelbine and gemcitabine are prescribed based on the results of small phase II...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Lung Cancer
Auteurs principaux: Zauderer, Marjorie G., Kass, Samantha L., Woo, Kaitlin, Sima, Camelia S., Ginsberg, Michelle S., Krug, Lee M.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4343315/
https://ncbi.nlm.nih.gov/pubmed/24690410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lungcan.2014.03.006
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!